Company
Seaport Therapeutics
We are developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders
Also known as Seaport Therapeutics, Inc.
- Business model
- B2B
- Legal name
- Seaport Therapeutics, Inc.
- seaporttx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Seaport Therapeutics is a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.
Funding snapshot
- Total raised
- $255MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- IPO, $255M2026-04-30
Funding rounds
- IPO
- $255M2026-04-30, Company stated
- Round, 2024
- $226M2024-10-18, SEC form D sold, 33 investors
Loading relationship preview